Income Statement BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 14/09/2024 am IST			5-day change	1st Jan Change
198.49 ^USD	+1.13%		+3.75%	+10.05%

12/09	Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	MT
11/09	Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	MT

9c567392a167bd13b92a.0-UxDmAA_mn1WRwAvcynOOm-QH5Mp0c4a20BMQRGHws.vpRUOzFSmhmkCHZKz4DtSZnMNTMIxQZIIwZ7RUALd2y7k39kNFmqA6Fvew

Published financial data: BEIGENE, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	428M	309M	1.18B	1.42B	2.46B
Total Revenues	428M	309M	1.18B	1.42B	2.46B
Cost of Goods Sold, Total	999M	1.37B	1.62B	1.93B	380M
Gross Profit	-570M	-1.06B	-448M	-511M	2.08B
Selling General & Admin Expenses, Total	388M	600M	992M	1.28B	1.51B
R&D Expenses	-	-	-	-	1.78B
Amortization of Goodwill and Intangible Assets - (IS)	1.33M	846K	750K	751K	3.5M
Other Operating Expenses, Total	390M	601M	992M	1.28B	3.29B
Operating Income	-960M	-1.66B	-1.44B	-1.79B	-1.21B
Interest Expense, Total	-10.3M	-17.97M	-28.21M	-19.1M	-4.23M
Interest And Investment Income	19.43M	19.97M	12.45M	71.58M	78.24M
Net Interest Expenses	9.13M	2M	-15.76M	52.48M	74.01M
Income (Loss) On Equity Invest.	-	-491K	-1.18M	-3.68M	-7.86M
Other Non Operating Income (Expenses)	7.17M	14.2M	9.32M	-189M	-39.49M
EBT, Excl. Unusual Items	-944M	-1.64B	-1.45B	-1.93B	-1.18B
Gain (Loss) On Sale Of Investments	-	12.48M	9.32M	-30.1M	-6.87M
Gain (Loss) On Sale Of Assets	-	11.31M	-	-	-
Other Unusual Items	-	-	-	-	363M
EBT, Incl. Unusual Items	-944M	-1.62B	-1.44B	-1.96B	-826M
Income Tax Expense	6.99M	-17.67M	-25.23M	42.78M	55.87M
Earnings From Continuing Operations	-951M	-1.6B	-1.41B	-2B	-882M
Net Income to Company	-951M	-1.6B	-1.41B	-2B	-882M
Minority Interest	1.95M	3.62M	-	-	-
Net Income - (IS)	-949M	-1.6B	-1.41B	-2B	-882M
Net Income to Common Incl Extra Items	-949M	-1.6B	-1.41B	-2B	-882M
Net Income to Common Excl. Extra Items	-949M	-1.6B	-1.41B	-2B	-882M
Per Share Items
Net EPS - Basic	-15.8	-19.13	-15.23	-19.43	-8.45
Basic EPS - Continuing Operations	-15.8	-19.13	-15.23	-19.43	-8.45
Basic Weighted Average Shares Outstanding	60.05M	83.47M	92.79M	103M	104M
Net EPS - Diluted	-15.8	-19.13	-15.23	-19.43	-8.45
Diluted EPS - Continuing Operations	-15.8	-19.13	-15.23	-19.43	-8.45
Diluted Weighted Average Shares Outstanding	60.05M	83.47M	92.79M	103M	104M
Normalized Basic EPS	-9.79	-12.25	-9.75	-11.7	-7.08
Normalized Diluted EPS	-9.79	-12.25	-9.75	-11.7	-7.08
American Depositary Receipts Ratio (ADR)	13	13	13	13	13
Supplemental Items
EBITDA	-941M	-1.63B	-1.39B	-1.73B	-1.12B
EBITA	-959M	-1.66B	-1.44B	-1.79B	-1.21B
EBIT	-960M	-1.66B	-1.44B	-1.79B	-1.21B
EBITDAR	-925M	-1.6B	-1.37B	-1.69B	-1.09B
Total Revenues (As Reported)	428M	309M	1.18B	1.42B	2.46B
Effective Tax Rate - (Ratio)	-0.74	1.09	1.75	-2.18	-6.77
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	39.3M	55.18M
Total Current Taxes	16.44M	10.51M	16.05M	39.3M	55.18M
Deferred Domestic Taxes	-4.74M	-1.15M	-	-	-
Deferred Foreign Taxes	-4.72M	-27.03M	-	3.48M	687K
Total Deferred Taxes	-9.45M	-28.18M	-41.28M	3.48M	687K
Normalized Net Income	-588M	-1.02B	-905M	-1.21B	-739M
Interest Capitalized	4.86M	338K	1.05M	2.59M	16.57M
Interest on Long-Term Debt	15.16M	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	927M	1.29B	1.46B	1.64B	1.78B
Net Rental Expense, Total	16.76M	21.75M	29.25M	34.07M	33.76M
Imputed Operating Lease Interest Expense	8.54M	7.59M	10.9M	9.16M	7.36M
Imputed Operating Lease Depreciation	8.22M	14.16M	18.35M	24.91M	26.4M
Stock-Based Comp., COGS (Total)	76.29M	93M	114M	139M	-
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	164M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	57.86M	90.48M	126M	164M	204M
Stock-Based Comp., Other (Total)	-	-	-	-	30K
Total Stock-Based Compensation	134M	183M	241M	303M	368M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	618M	1.38B	4.38B	3.87B	3.17B
Short Term Investments	365M	3.27B	2.24B	667M	2.6M
Total Cash And Short Term Investments	983M	4.65B	6.62B	4.54B	3.17B
Accounts Receivable, Total	70.88M	60.4M	483M	173M	358M
Other Receivables	1.93M	19.27M	17.06M	25.82M	37.86M
Total Receivables	72.81M	79.67M	500M	199M	396M
Inventory	28.55M	89.29M	243M	282M	416M
Prepaid Expenses	9.5M	57.74M	139M	83.09M	88.26M
Restricted Cash	288K	307K	328K	196K	11.47M
Other Current Assets, Total	78.81M	83.01M	114M	106M	117M
Total Current Assets	1.17B	4.96B	7.61B	5.21B	4.2B
Gross Property Plant And Equipment	362M	522M	829M	1.13B	1.67B
Accumulated Depreciation	-36.71M	-73.35M	-124M	-171M	-249M
Net Property Plant And Equipment	325M	448M	705M	956M	1.42B
Long-term Investments	-	49.34M	101M	91.78M	89.64M
Goodwill	109K	109K	109K	109K	-
Other Intangibles, Total	5.85M	5M	46.68M	40.62M	57.14M
Deferred Tax Assets Long-Term	37.89M	65.96M	110M	-	-
Other Long-Term Assets, Total	70.82M	71.38M	69.03M	83.8M	35.72M
Total Assets	1.61B	5.6B	8.65B	6.38B	5.81B
Liabilities
Accounts Payable, Total	122M	232M	262M	295M	315M
Accrued Expenses, Total	120M	390M	534M	480M	589M
Short-term Borrowings	-	335M	425M	315M	660M
Current Portion of Long-Term Debt	-	307K	2.82M	14.14M	28.58M
Current Portion of Leases	10.81M	13.9M	21.92M	24.04M	21.95M
Current Income Taxes Payable	13.45M	20.38M	21.4M	25.19M	22.95M
Unearned Revenue Current, Total	-	-	187M	214M	-
Other Current Liabilities	43.41M	84.2M	145M	102M	173M
Total Current Liabilities	310M	1.08B	1.6B	1.47B	1.81B
Long-Term Debt	241M	184M	202M	209M	198M
Long-Term Leases	25.83M	29.42M	43.04M	34.52M	22.25M
Unearned Revenue Non Current	46.39M	49.14M	267M	80.2M	34.5M
Pension & Other Post Retirement Benefits	-	8.11M	7.81M	7.76M	15M
Deferred Tax Liability Non Current	10.53M	10.79M	14.17M	16M	16.49M
Other Non Current Liabilities	171K	375M	270M	180M	172M
Total Liabilities	634M	1.73B	2.4B	2B	2.27B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	79K	118K	133K	135K	135K
Additional Paid In Capital	2.93B	7.41B	11.19B	11.54B	11.6B
Retained Earnings	-1.96B	-3.55B	-4.97B	-7.08B	-7.96B
Comprehensive Income and Other	-8M	6.94M	17.95M	-77.42M	-99.45M
Total Common Equity	962M	3.87B	6.24B	4.38B	3.54B
Minority Interest	16.15M	-	-	-	-
Total Equity	978M	3.87B	6.24B	4.38B	3.54B
Total Liabilities And Equity	1.61B	5.6B	8.65B	6.38B	5.81B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	77.53M	91.6M	103M	104M	105M
ECS Total Common Shares Outstanding	61.64M	91.6M	103M	104M	105M
Book Value / Share	15.61	42.24	60.8	42.02	33.82
Tangible Book Value	956M	3.86B	6.2B	4.34B	3.48B
Tangible Book Value Per Share	15.51	42.18	60.35	41.63	33.28
Total Debt	277M	562M	695M	597M	930M
Net Debt	-705M	-4.09B	-5.92B	-3.94B	-2.24B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	8.11M	7.81M	7.76M	15M
Debt Equivalent Oper. Leases	134M	174M	234M	273M	270M
Minority Interest, Total (Incl. Fin. Div)	16.15M	-	-	-	-
Account Code - Inventory Valuation	6	5	5	5	6
Inventories - Raw Materials, Total	-	19.33M	78.14M	88.96M	149M
Inventories - Work In Process, Total	-	1.38M	9.4M	20.89M	39.1M
Inventories - Finished Goods, Total	28.55M	68.58M	155M	173M	228M
Land - (BS)	-	-	65.48M	65.48M	65.48M
Buildings, Total	110M	112M	144M	222M	232M
Machinery, Total	110M	175M	238M	335M	392M
Full Time Employees	3.5K	5.3K	8K	9K	10.6K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	112K	415K	211K	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-949M	-1.6B	-1.41B	-2B	-882M
Depreciation & Amortization - CF	17.29M	30.94M	44.74M	62.3M	80.44M
Amortization of Goodwill and Intangible Assets - (CF)	1.33M	846K	750K	751K	3.5M
Depreciation & Amortization, Total	18.62M	31.79M	45.49M	63.05M	83.94M
Amortization of Deferred Charges, Total - (CF)	-	-	965K	3.22M	3.74M
(Gain) Loss From Sale Of Asset	-	-11.31M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-11.83M	-7.63M	22M	16.22M
Asset Writedown & Restructuring Costs	69M	-4.49M	-28.99M	-27.74M	-8.49M
Stock-Based Compensation (CF)	134M	183M	241M	303M	368M
Other Operating Activities, Total	-12.58M	-24.79M	-17.58M	11.11M	-368M
Change In Accounts Receivable	-29.82M	10.36M	-423M	304M	-188M
Change In Inventories	-12.31M	-58.91M	-153M	-56.69M	-141M
Change In Accounts Payable	2.22M	95.84M	20.01M	-4.35M	21.48M
Change in Unearned Revenues	-27.98M	-	408M	-152M	-256M
Change In Income Taxes	7.57M	2.32M	-	-	-
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	49.49M	101M	30.3M	41.14M	193M
Cash from Operations	-750M	-1.28B	-1.3B	-1.5B	-1.16B
Capital Expenditure	-89.61M	-118M	-263M	-325M	-562M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-2.02M	-	-	-
Sale (Purchase) of Intangible assets	-69M	-110M	-51.91M	-144M	-34.36M
Investment in Marketable and Equity Securities, Total	713M	-2.94B	956M	1.55B	656M
Cash from Investing	554M	-3.17B	641M	1.08B	60M
Short Term Debt Issued, Total	-	-	406M	314M	662M
Long-Term Debt Issued, Total	67.49M	434M	16.84M	37.37M	22.5M
Total Debt Issued	67.49M	434M	423M	351M	684M
Short Term Debt Repaid, Total	-	-	-322M	-417M	-310M
Long-Term Debt Repaid, Total	-32.81M	-144M	-	-	-13.69M
Total Debt Repaid	-32.81M	-144M	-322M	-417M	-323M
Issuance of Common Stock	47M	4.33B	3.54B	46.96M	55.71M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	4M	588M	-	-	-
Cash from Financing	85.68M	5.2B	3.64B	-18.97M	416M
Foreign Exchange Rate Adjustments	-9.51M	18.23M	14.04M	-69.38M	-8.08M
Net Change in Cash	-120M	769M	2.99B	-508M	-689M
Supplemental Items
Cash Interest Paid	4.32M	44.13M	29.97M	25.17M	19.75M
Cash Income Tax Paid (Refund)	8.98M	10.6M	15.7M	29.5M	56M
Levered Free Cash Flow	-578M	-752M	-1.21B	-943M	-1.27B
Unlevered Free Cash Flow	-572M	-741M	-1.19B	-931M	-1.27B
Change In Net Working Capital	-34.21M	-307M	262M	-288M	372M
Net Debt Issued / Repaid	34.68M	290M	102M	-65.94M	361M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-31.07	-28.73	-12.64	-15.01	-12.4
Return on Total Capital	-37.41	-36.44	-15.84	-18.96	-15.99
Return On Equity %	-69.59	-66.03	-27.95	-38.11	-22.26
Return on Common Equity	-70.23	-66.1	-27.95	-38.11	-22.26
Margin Analysis
Gross Profit Margin %	-133.19	-342.1	-38.07	-36.09	84.55
SG&A Margin	90.67	194.31	84.31	90.31	61.22
EBITDA Margin %	-219.81	-526.39	-118.58	-122	-45.74
EBITA Margin %	-223.85	-536.41	-122.38	-126.4	-49.01
EBIT Margin %	-224.16	-536.69	-122.44	-126.45	-49.15
Income From Continuing Operations Margin %	-221.99	-518.18	-120.15	-141.52	-35.86
Net Income Margin %	-221.53	-517.01	-120.15	-141.52	-35.86
Net Avail. For Common Margin %	-221.53	-517.01	-120.15	-141.52	-35.86